...
机译:CYP2C19基因型对侵袭性真菌感染的成人伏立康唑暴露的影响
Univ Florida Coll Pharm Dept Pharmacotherapy &
Translat Res Gainesville FL USA;
Univ Florida Coll Pharm Dept Pharmacotherapy &
Translat Res Gainesville FL USA;
Univ Florida Hlth Shands Hosp Gainesville FL USA;
Univ Florida Hlth Shands Hosp Gainesville FL USA;
Univ Florida Coll Pharm Ctr Pharmacogen Gainesville FL USA;
Univ Florida Coll Pharm Dept Pharmaceut Orlando FL USA;
Univ Florida Coll Med Dept Med Div Hematol &
Oncol Gainesville FL USA;
Univ Florida Coll Pharm Dept Pharmaceut Orlando FL USA;
Univ Florida Coll Pharm Dept Pharmacotherapy &
Translat Res Gainesville FL USA;
Univ Florida Coll Pharm Dept Pharmacotherapy &
Translat Res Gainesville FL USA;
Univ Florida Coll Pharm Dept Pharmacotherapy &
Translat Res Gainesville FL USA;
Univ Florida Coll Pharm Dept Pharmacotherapy &
Translat Res Gainesville FL USA;
CYP2C19*17; invasive fungal infections; rapid and ultrarapid metabolizer phenotypes; subtherapeutic trough plasma concentration; voriconazole;
机译:CYP2C19基因型对侵袭性真菌感染的成人伏立康唑暴露的影响
机译:中国西南汉族侵袭性真菌感染患者CYP2C19基因型与血浆伏立康唑暴露的相关性
机译:CYP2C19遗传多态性对侵袭性真菌感染患者伏立康唑暴露的影响
机译:从严重侵入性群体感染患者中分离的eMM49基因分型菌株中SKA基因表达的增加
机译:侵袭性真菌感染疫苗的开发
机译:CYP2C19基因型对伏立康唑暴露于成人侵袭性真菌感染的影响。
机译:CYP2C19,CYP3A4,ABCB1和FMO3基因型对浸润性真菌感染患者血浆Voriconazole的影响